Casi PharmaceuticalsCASIF
13F holders, Q1 2026 (March 31)1holders −15
0new positions
15sold out
$0.11avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Casi Pharmaceuticals Inc. (CASIF) in their 13F filings, down 15 from Q4 2025. 0 opened new positions and 15 sold out. The largest holder was Simplex Trading, LLC ($25).
- Company
- Casi Pharmaceuticals Inc.
- CUSIP
- G1933S101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 15 | $1.1M |
All 13F filers, Q4 2025 → Q1 2026: 95 shares bought and 1,251,996 shares sold, net −1,251,901 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Simplex Trading, LLC | 0.00% | Add +71.4% | 228 | $25 |
"% of holder's portfolio" is CASIF's weight in each manager's 13F, not the share of Casi Pharmaceuticals Inc. the manager owns.